Document:

<PAGE>   1
                                                                   EXHIBIT 10.37

                                LICENSE AGREEMENT

        This Agreement effective the 9th day of March 2000 is by and between
Henry B. Freedman, an individual having an address of Box 2413, Springfield,
Virginia 22152 (hereinafter "Licensor"); and printCafe, Inc., a Delaware
corporation, having a place of business at 40 24th Street, 5th Floor,
Pittsburgh, Pennsylvania 15222 (hereinafter "Licensee") (collectively, the
"Parties").

Recitals

        WHEREAS, Licensor is the owner of the Licensed Patent; and

        WHEREAS, Licensee is desirous of acquiring from Licensor a non-exclusive
license under the Licensed Patent; and

        NOW, THEREFORE, for and in consideration of the foregoing premises and
of the mutual covenants set forth herein, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the
Parties, intending to be legally bound, covenant and agree as follows:

Definition

        As used herein the term "Licensed Patent" shall mean U.S. Patent No.
4,839,829 entitled Automated Printing Control System (hereinafter "the `829
Patent") and all divisionals, continuations, continuations-in-part, reissues,
reexaminations, and/or extensions thereof, including all foreign counterparts of
the foregoing, and all other patents and/or patent applications that have been
or shall be filed and/or issued in the United States and all foreign countries
on any of the improvements included in the `829 Patent.

Article I - Grant of License

        A. Licensor hereby grants to Licensee under the terms and conditions
hereinafter stated (i) a non-exclusive right and license to make, advertise,
have made, use and import into the United States systems (which may include
hardware, software and/or combinations of hardware and software) embodying the
claimed invention of the Licensed Patent (hereinafter "Systems") for its own
use; and (ii) a non-exclusive right and license to allow others ("End-Users") to
make use of and/or to otherwise access (but

<PAGE>   2

not to copy, download, disseminate or otherwise obtain or appropriate) such
Systems through Licensee's Internet Web Site ("Web Site Use rights"). As used
herein, the term Web Site shall mean a computer-based resource, including the
hardware and/or software thereof, which can be reached by other computers or
network-capable appliances over one or more computer networks using a Uniform
Resource Locator (URL) and a Web Browser or similar application, or by other
such means. It is expressly understood and agreed between Licensor and Licensee
that (i) Licensee may deploy Systems [*] that may be physically separate from
Licensee's address noted above, (ii) Licensor reserves the exclusive right to
grant further licenses to other users of Systems of the Licensed Patent, and
(iii) third parties acquire no license or other rights to make or sell Systems
under this Agreement.

        B. Licensee shall not have the right to grant any sub-license or other
rights to third parties, other than the Web Site Use rights specified above,
under the rights granted to it by this Agreement.

        C. Licensor hereby releases, acquits and forever discharges Licensee;
its subsidiaries and affiliated companies; its successors in interest; its sales
representatives, distributors and customers including End-Users (collectively
referred to as "the Released Entities"); and each of the Released Entities'
respective owners, agents, representatives, attorneys, employees, officers,
directors, and stockholders from and against any and all claims, demands, causes
of action or liabilities of any kind, character or nature whatsoever, for past
and/or present infringements of the Licensed Patent arising out of the offering
for sale, making, having made, using, selling or importing of Systems. The
purpose and intent of this release is to ensure that Licensee, its various
representatives, distributors and customers are immune from suit for any past
and/or present infringement, including any claims of direct infringement,
contributory infringement and/or inducement of infringement by others, of the
License Patent arising out of the offering for sale, making, having made, using,
selling or importing of Systems and/or parts thereof.

--------

* Material has been omitted pursuant to a request for confidential treatment.

                                       2
<PAGE>   3

Article II - Compensation

        A. As consideration for the license granted herein and during the Term
of this Agreement, Licensee agrees to pay Licensor [*] (the "License Fee") to be
paid as follows:

               1. [*] within ten (10) days after the effective date of this
                      Agreement;

               2. [*] by January 2, 2001; and

               3. [*] by January 2, 2002.

        B. The payments of the Licensee Fee shall be made even in the event that
there is a finding by a court of competent jurisdiction, that one or more claims
of the Licensed Patent is/are invalid, and such a finding shall not terminate,
or give rise to any rights by Licensee to terminate, this Agreement. Licensee
agrees that it will not challenge the validity or enforceability of the `829
Patent.

Article III - Other Licensees

        A. From the effective date of this Agreement until the expiration of the
`829 Patent, Licensor agrees that it will not, except upon consent of the
Licensee in writing, license the Licensed Patent to other e-commerce printing
entities [*] on more favorable terms than those agreed to between the parties
concerning the Licensed Patent. [*].

Article IV - Warranties and Obligations

        A. Licensor warrants that, at the time of the execution of this
Agreement, it has the legal right and power to grant to Licensee the rights
granted under this Agreement.

        B. Licensor warrants that it has not granted any rights or made any
commitments relative to the granting of any rights, which are inconsistent with
the rights granted to Licensee under this Agreement.

        C. Licensor makes no other representations or warranties, express or
implied, and does not assume any liability with respect to infringement of
patents or other rights of third parties due to Licensee's operation under the
license granted herein.

        D. Licensor shall have no obligation to enforce the Licensed Patent
against any third party or to defend any action or suit which challenges the
validity of the

--------

* Material has been omitted pursuant to a request for confidential treatment.

                                       3
<PAGE>   4

Licensed Patent. Licensee shall have no right to enforce the Licensed Patent
against any third party.

        E. The Parties agree to take reasonable steps to ensure the
confidentiality of the terms of this Agreement and, accordingly, any release of
information relating to this Agreement must be reviewed and approved in advance
by each of the Parties, except that copies of this Agreement may be made
available to government agencies in compliance with regulations thereof
requiring the disclosure of material agreements. Neither party shall be liable
for disclosure of the terms of this Agreement if made in response to a valid
order of a court or authorized agency of government; provided that ten (10)
days' notice first be given to the other part so a protective order, if
appropriate, may be sought by such party. Furthermore, either party may
disclose, in confidence, the terms of this Agreement to its financial
consultants, tax planners and/or advisors, attorneys, underwriters, and/or third
parties under an obligation to the disclosing party to preserve the secrecy of
the disclosing party's confidential information, without the consent of the
other party. Anything to the contrary notwithstanding, Licensor may disclose the
terms of this Agreement under suitable confidentiality terms in connection with
further licensing of the Licensed Patent.

        F. The Parties shall cooperate in reasonable efforts to publicize the
'829 Patent through the joint dissemination of a press release in a form
substantially similar to that attached hereto within sixty (60) days of the
Effective Date. Nothing herein shall preclude further announcements by the
Parties.

                                       4
<PAGE>   5

Article V - Marking

        Licensee shall mark and prominently display the legend "U.S. Patent
4,839,829" on all literature, users manuals and documentation produced that
promotes the system under the Licensed Patent and on all web sites that promote
or feature the system of the License Patent. Furthermore, Licensee must
prominently list the Licensed Patent as licensed from Henry B. Freedman and must
prominently list the web site and telephone number of Henry B. Freedman as the
owner of the Licensed Patent on Licensee's Internet web site.

Article VI - Term and Termination

        A. Unless sooner terminated as provided below, this Agreement shall
remain in effect until the expiration of the last to expire of the Licensed
Patent (the Term).

        B. If Licensee, at any time, defaults in any payments due hereunder or
breaches any material term of this Agreement, Licensor shall have the right to
give notice of such default or breach to Licensee, in writing, and, if the
default is not cured within thirty (30) days after receipt of the notice,
Licensor, at its option, may immediately terminate this Agreement and license
granted herein by giving written notice of termination to Licensee.

Article VII - Administration

        A. This Agreement shall be binding upon and shall inure to the benefit
of and be enforceable by Licensor and its successors in interest and assigns.
This Agreement and the rights granted hereunder are personal to Licensee and
Licensee may not sell, pledge, assign or transfer this Agreement and the rights
granted hereunder nor delegate any duties or obligations hereunder, without the
written consent of the Licensor, except that a change of ownership or control of
Licensee (whether by merger, operation of law, a sale of all or substantially
all of the assets of Licensee or otherwise) shall not be deemed an impermissible
assignment of this Agreement. Licensee agrees to promptly notify Licensor of any
change of ownership or control of Licensee. For purposes of this Article VII, a
change in ownership or control with respect to Licensee means a transaction
resulting in (i) the sale, disposition or other transfer of greater than fifty
percent (50%) of the outstanding voting securities of Licensee by the current
stockholders of Licensee

                                       5
<PAGE>   6

other than by way of merger, acquisition or operation of law; (ii) a sale of all
or substantially all of the assets of Licensee; or (iii) the acquisition of the
beneficial ownership (as determined with reference to Rule 13d-3 of the General
Rules and Regulations of the Securities Exchange Act of 1934, as amended, in
effect on the date of this Agreement) of greater than fifty percent (50%) of the
outstanding voting securities of Licensee.

        B. This Agreement shall be construed, interpreted and applied in
accordance with the law of Virginia, without regard to that State's body of law
regarding conflicts of law.

        C. The Parties agree that if in the event any either party shall need to
pursue its rights under this Agreement and license in a court of competent
jurisdiction, the court shall award to the prevailing party its cost involved in
pursuing the dispute, including attorneys' fees, and such award shall be paid by
the other party.

        D. In the event that any provision of this Agreement is determined by a
court of competent jurisdiction to be unenforceable or invalid, the Parties
hereto agree that such provision found to be unenforceable or invalid shall be
enforced to the full extent permitted and, in any event, all other provisions of
this Agreement shall remain valid and enforceable as if the unenforceable or
invalid portion had never been made a part hereof. Furthermore, no damages for
any act of infringement of the Licensed Patent by Licensee or any of the
Released Entities shall accrue from the Effective Date.

        E. All notices required to be provided for by the terms of this
Agreement shall be given in writing and shall be deemed to have been duly given
if addressed and sent by registered or certified mail, return receipt requested,
with the postage prepaid, or by overnight courier services to the address of
such party as set forth above or to such other address as either party may, by
written notice, appoint for that purpose with a copy to counsel for each party.
Counsel are as follows:
                             Licensor:

                             Ronald L. Panitch, Esquire
                             Akin, Gump, Strauss, Hauer & Feld, L.L.P.
                             One Commerce Square
                             2005 Market Street, 22nd Floor
                             Philadelphia, PA  19103
                             Telephone (215) 965-1300

                                       6
<PAGE>   7

                             Licensee:

        F. With respect to the subject matter of this Agreement, the foregoing
constitutes the entire and only understanding between the Parties, and this
Agreement supersedes any prior or collateral agreements or understandings
between the Parties with respect to the subject matter thereof. No terms,
conditions or statements purporting to modify, vary or waive the terms of this
Agreement shall be effective unless made in writing and signed by the Parties
hereto. This Agreement is the product of an arms-length negotiation between the
Parties, with each of the Parties being represented by legal counsel of their
choice. Nothing in this Agreement and the negotiations leading to its
consummation shall be construed as offering any tax-related advice to either of
the Parties by the other party.

               IN WITNESS WHEREOF, the Parties hereto have caused this Agreement
to be executed by its authorized representatives.

                                    Henry B. Freedman

Date:____________________           ____________________________________

                                    printCafe, Inc.

Date:____________________           BY:_________________________________

                                    NAME:_______________________________

                                    TITLE:______________________________

                                       7
<PAGE>   8

[*]

--------

* Material has been omitted pursuant to a request for confidential treatment.

                                       8<PAGE>   1
                                                                   EXHIBIT 10.38

THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE SECURITIES LAWS. THESE
SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT
BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE
SECURITIES LAWS, PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. THE ISSUER
OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE
SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS
IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

                                 printCafe, Inc.

                           WARRANT TO PURCHASE SHARES
                                 OF COMMON STOCK

        THIS WARRANT CERTIFIES THAT, for good and valuable consideration,
Andersen Consulting LLP (the "HOLDER"), is entitled to purchase, subject to the
terms of this Warrant, up to 521,739 paid and nonassessable shares of Common
Stock (as adjusted pursuant to Article 4 hereof, the "SHARES") of printCafe,
Inc., a Delaware corporation (the "COMPANY"), at the price of FIVE DOLLARS AND
EIGHTY CENTS ($5.80) per Share (such price and such other price as shall result
from time to time from the adjustments specified in Article 4 hereof, the
"WARRANT PRICE"), subject to the provisions and upon the terms and conditions
set forth in this Warrant. As used herein, (a) the term "COMMON STOCK" shall
mean the Company's common stock, par value $.0001 per share, and any capital
stock into or for which such Common Stock may hereafter be converted or
exchanged, and (b) the term "DATE OF GRANT" shall mean the Date of Grant listed
on the signature page hereof.

ARTICLE 1. TERM. The purchase right represented by this Warrant is exercisable,
in whole or in part, at any time and from time to time from the Date of Grant
through 5:00 p.m. New York City local time on the date which is the earlier of
(i) four years after the Date of Grant, (ii) three (3) years after the closing
of a firmly underwritten initial public offering (the "IPO") of the Common Stock
effected pursuant to a registration statement (or its successor) filed under the
Securities Act of 1933, as amended (the "ACT"), (iii) the closing date of a
merger or consolidation of the Company with or into any other entity, including
a reverse triangular merger involving the Company (other than a merger or
consolidation in which the holders of the voting power of the Company
immediately prior to such consolidation or merger hold a majority of the
surviving or resulting entity immediately following such consolidation or
merger), or (iv) the closing date of the sale, lease, exchange, conveyance or
other disposition of all or substantially all of the assets of the Company.

<PAGE>   2

ARTICLE 2. EXERCISE.

        2.1 Subject to Article 1 hereof, this Warrant be exercisable as follows:
(i) [1] Shares shall be exercisable immediately upon the Date of Grant, and (ii)
[*] shall vest on a quarterly basis for a [*] period beginning on the date which
the Company installs an internet based print procurement system (the "Web Site")
for Holder, with the amount vesting each quarter equal to [*] multiplied by a
fraction, the numerator of which is the amount of printing Holder purchases for
its internal need through the Web Site during such [*] and the denominator of
which is [*]; provided, however, that in no event shall Holder vest in Warrants
to purchase greater than [*] Shares pursuant to this subsection 2.1(ii).

        2.2 Method of Exercise; Payment. Subject to Article 1 hereof and the
vesting schedule set forth in Section 2.1, the purchase right represented by
this Warrant may be exercised by the Holder, in whole or in part and from time
to time, at the election of the Holder, by (a) the surrender of this Warrant
(with the notice of exercise substantially in the form attached hereto as
EXHIBIT A duly completed and executed) at the principal office of the Company
and by the payment to the Company, by certified check or by wire transfer to an
account or accounts designated by the Company of an amount equal to the then
applicable Warrant Price multiplied by the number of Shares then being
purchased, or (b) exercise of the Conversion Right provided for in Article 3
hereof.

        2.3 Delivery of Certificate and New Warrant. The person or persons in
whose name(s) any certificate(s) representing Shares shall be issuable upon
exercise of this Warrant shall be deemed to have become the holder(s) of record
of, and shall be treated for all purposes as the record holder(s) of, the Shares
represented thereby (and such Shares shall be deemed to have been issued)
immediately prior to the close of business on the date or dates upon which this
Warrant is exercised. In the event of any exercise of the rights represented by
this Warrant, the Company shall deliver to the Holder as soon as practicable and
in any event within thirty (30) days after such exercise (a) a certificate of
the Company executed by a duly authorized officer of the Company to the effect
that the representations and warranties set forth in Section 5.1 hereof are true
and correct as of the date thereof (a "COMPLIANCE CERTIFICATE"), (b)
certificates for the Shares so purchased and (c) unless this Warrant has been
fully exercised or expired, a new Warrant representing the portion of the
Shares, if any, with respect to which this Warrant shall not then have been
exercised.

        2.4 Stock Fully Paid; Reservation of Shares. All Shares that may be
issued upon the exercise of this Warrant will, upon issuance pursuant to the
terms and conditions herein, be fully paid and nonassessable, and free from all
taxes, liens and charges (except for taxes, liens and charges applicable to the
Holder) with respect to the issue thereof. During the period within which the
rights represented by this Warrant may be exercised, the Company will at all
times have authorized, and reserved for the purpose of the issue upon exercise
of the purchase rights evidenced by this Warrant, a sufficient number of shares
of Common Stock to provide for the exercise of the rights represented by this
Warrant.

        2.5 Replacement of Warrants. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of loss, theft

--------

* Material has been omitted pursuant to a request for confidential treatment.

                                       2
<PAGE>   3

or destruction, on delivery of an indemnity agreement reasonably satisfactory in
form and amount to the Company, and, in the case of mutilation, on surrender and
cancellation of this Warrant, the Company at its expense shall execute and
deliver, in lieu of this Warrant, a new warrant of like tenor.

        2.6 No Assignment. The Holder of this Warrant shall not be entitled,
without obtaining the prior written consent of the Company, to assign, by
operation of law or otherwise, its interest in this Warrant in whole or in part
to any person or persons.

        2.7 Other Agreements. Except in connection with Holder's contingent
exercise of its Conversion Right (as defined in Section 3.1) in connection with
the closing of the IPO as more fully described in Article 3, Holder hereby
acknowledges and agrees that, in the event that Holder exercises this Warrant
prior to the closing of the IPO, Holder will execute and become a party to that
certain Right of First Refusal and Co-Sale Agreement substantially in the form
attached hereto as Exhibit B hereto and that certain Voting Agreement
substantially in the form attached hereto as Exhibit C hereto, as such
agreements shall be amended to the date of exercise by Holder, with respect to
the Shares received by Holder in connection with such exercise of this Warrant.

ARTICLE 3. CONVERSION RIGHT.

        3.1 Conversion Right. In addition to and without limiting the rights of
the Holder under the terms of this Warrant, the Holder shall have the right to
convert this Warrant or any portion thereof which is fully vested at such time
(the "CONVERSION RIGHT") into shares of Common Stock at any time or from time to
time during the term of this Warrant. Upon exercise of the Conversion Right with
respect to a particular number of Shares (the "CONVERTED WARRANT SHARES"), the
Company shall deliver to the Holder (without payment by the Holder of any
exercise price or any cash or other consideration) that number of shares of
fully paid and nonassessable Common Stock determined by dividing (a) the
aggregate Fair Market Value (as determined pursuant to Section 3.3) of the
Converted Warrant Shares on the Conversion Date (as defined in Section 3.2
below) minus the aggregate Warrant Price of such Converted Warrant Shares by (b)
the Fair Market Value of one share of Common Stock.

        3.2 Method of Exercise. In the event that the Holder elects to exercise
the Conversion Right, the Holder shall surrender this Warrant at the principal
office of the Company together with a written statement specifying that the
Holder thereby intends to exercise the Conversion Right and indicating the
number of Shares which are being surrendered (referred to in Section 3.1 hereof
as the Converted Warrant Shares) in exercise of the Conversion Right. Such
conversion shall be effective upon receipt by the Company of this Warrant
together with the aforesaid written statement or on such later date as is
specified therein (the "CONVERSION DATE") and, at the election of the Holder,
may be made contingent upon the closing of the IPO. Certificates for the Shares
issuable upon exercise of the Conversion Right, a Compliance Certificate and, if
applicable, a new warrant evidencing the balance of the Shares remaining subject
to this Warrant, shall be issued as of the Conversion Date and shall be
delivered to the Holder within thirty (30) days following the Conversion Date.

                                       3
<PAGE>   4

        3.3 Determination of Fair Market Value. For purposes of this Article 3,
"FAIR MARKET VALUE" of a share of Common Stock as of a particular date (the
"DETERMINATION DATE") shall mean:

               (a) If the Conversion Right is exercised in connection with and
contingent upon the IPO, then the initial "Price to Public" specified in the
final prospectus with respect to such offering.

               (b) If the Conversion Right is not exercised in connection with
the IPO, then as follows:

                      (i) If traded on a securities exchange, the Fair Market
Value of the Common Stock shall be deemed to be the average of the closing
prices of the Common Stock on such exchange over the 30-day period ending five
(5) business days prior to the Determination Date;

                      (ii) If traded over-the-counter, the Fair Market Value of
the Common Stock shall be deemed to be the average of the closing bid prices of
the Common Stock over the 30-day period ending five (5) business days prior to
the Determination Date; or

                      (iii) If there is no public market for the Common Stock,
then Fair Market Value shall be determined in good faith by the Board of
Directors of the Company.

        3.4 Fractional Shares. No fractional Shares shall be issuable upon
exercise of this Warrant pursuant to Section 2.1 or exercise of the Conversion
Right pursuant to this Article 3, but in lieu of such fractional shares the
Company shall make a cash payment therefor based on the Fair Market Value of the
Shares on the date of exercise or conversion as determined pursuant to Section
3.3.

ARTICLE 4. ADJUSTMENTS TO THE SHARES.

        4.1 Stock Dividends. If the Company declares or pays a dividend on the
Common Stock payable in share of Common Stock (except any distribution
specifically provided for in Sections 4.2 or 4.3), then upon exercise of this
Warrant, for each Share acquired, the Holder shall receive, without cost to the
Holder, the total number and kind of securities to which the Holder would have
been entitled had the Holder owned the Shares of record as of the date the
dividend or subdivision occurred.

        4.2 Reclassification, Exchange, Substitution or Merger. In case of any
reclassification, exchange or change of securities of the class issuable upon
exercise of this Warrant (other than a change in par value, or from par value to
no par value, or from no par value to par value, or as a result of a subdivision
or combination), the Company shall duly execute and deliver to the Holder a new
warrant (in form and substance satisfactory reasonably acceptable to the Holder)
providing that the Holder shall have the right to exercise such new Warrant and
upon such exercise to receive, in lieu of each share of Common Stock theretofore
issuable upon exercise of this Warrant, the kind and amount of shares of stock,
other securities, money and property receivable upon such reclassification or
change by a holder of one share Common Stock. Such new warrant shall provide for
adjustments which shall be as nearly equivalent as

                                       4
<PAGE>   5

may be practicable to the adjustments provided for in this Article 4. The
provisions of this Section 4.2 shall similarly apply to successive
reclassifications or changes.

        4.3 Adjustments for Subdivisions or Combinations. If the Company at any
time while this Warrant remains outstanding and unexpired shall subdivide or
combine its Common Stock, the Exercise Price and the number of Shares issuable
upon exercise hereof shall be proportionately adjusted.

        4.4 Minimum Adjustment. No adjustment in the Exercise Price pursuant to
this Article 4 shall be required unless the adjustment would require an increase
or decrease of at least $.05 in such Exercise Price; provided, however, that any
adjustments which by reason of this Section 4.4 are not required to be made,
shall be carried forward and taken into account in any subsequent adjustment.
All calculations under this Article 4 shall be to the nearest cent or the
nearest Share, as the case may be.

        4.5 Certificate as to Adjustments. Upon each adjustment of the Warrant
Price and the number of Shares acquirable hereunder, the Company, at its
expense, shall promptly compute such adjustment and furnish the Holder with a
certificate of its Chief Financial Officer setting forth such adjustment and the
facts upon which such adjustment is based. The Company shall, upon written
request, furnish the Holder a certificate setting forth the Warrant Price in
effect on the date thereof and the number of Shares acquirable hereunder on such
date and the series of adjustments leading to such Warrant Price and share
number.

ARTICLE 5. REPRESENTATIONS AND COVENANTS OF THE COMPANY.

        5.1 Representations and Warranties. The Company hereby represents and
warrants to the Holder that:

               (a) This Warrant has been duly authorized and executed by the
Company and is a valid and binding obligation of the Company enforceable in
accordance with its terms, subject to laws of general application relating to
bankruptcy, insolvency and the relief of debtors and the rules of law or
principles at equity governing specific performance, injunctive relief and other
equitable remedies;

               (b) The Shares have been duly authorized and reserved for
issuance by the Company and, when issued in accordance with the terms hereof,
will be validly issued, fully paid and non-assessable;

               (c) The rights, preferences, privileges and restrictions granted
to or imposed upon the Shares and the holders thereof are as set forth in the
Company's Certificate of Incorporation, as amended to the Date of the Grant;

               (d) The execution and delivery of this Warrant is not, and the
issuance of the Shares upon exercise of this Warrant in accordance with the
terms hereof will not be, inconsistent with the Company's Certificate of
Incorporation or bylaws and do not and will not conflict with or contravene any
provision of, or constitute a default under, any material

                                       5
<PAGE>   6

indenture, mortgage, contract or other instrument of which the Company is a
party or by which it is bound; and

               (e) There are no actions, suits, investigations or proceedings
pending or, to the knowledge of the Company, threatened against the Company in
any court or before any governmental commission, board or authority which, if
adversely determined, will have a material adverse effect on the ability of the
Company to issue the Shares upon exercise of this Warrant.

        5.2 Notice of Certain Events. If the Company proposes at any time to (a)
declare any dividend or distribution upon the Common Stock, whether in cash,
property, stock, or other securities and whether or not a regular cash dividend;
(b) offer for subscription pro rata to the holders of any class or series of its
stock any additional shares of stock of any class or series or other rights; or
(c) effect any reclassification or recapitalization of the Common Stock, then,
in connection with each such event, the Company shall give the Holder (1) prompt
prior written notice of the date on which a record will be taken for such
dividend, distribution, or subscription rights or for determining rights to
vote, if any, in respect of the matters referred to in (c) above; and (2) in the
case of the matters referred to in (c) above, prompt prior written notice of the
date when the same will take place.

        5.3 Mergers. The Company shall provide the Holder with at least ten (10)
business days' notice of the terms and conditions of any of the following
potential transactions: (i) the sale, lease, exchange, conveyance or other
disposition of all or substantially all of the Company's property or business,
or (ii) its merger into or consolidation with any other corporation (other than
a wholly-owned subsidiary of the Company), or any transaction (including a
merger or other reorganization) or series of related transactions, in which a
majority of the voting power of the Company is disposed of.

        5.4 Rights as Stockholders; Information. The Holder, as such, shall not
be entitled to vote or receive dividends or be deemed the holder of Common Stock
or any other securities of the Company which may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be
construed to confer upon the Holder, as such, any of the rights of a stockholder
of the Company or any right to vote for the election of directors or upon any
matter submitted to stockholders at any meeting thereof, or to receive notice of
meetings, or to receive dividends or subscription rights or otherwise until this
Warrant shall have been exercised and the Shares purchasable upon the exercise
hereof shall have become deliverable, as provided herein. Notwithstanding the
foregoing, the Company will transmit to the Holder such information, documents
and reports as are generally distributed to the holders of any class or series
of the securities of the Company concurrently with the distribution thereof to
the stockholders.

ARTICLE 6. SECURITIES LAW COMPLIANCE.

        6.1 Compliance with the Act. This Warrant may not be sold, assigned,
pledged, hypothecated, encumbered or in any other manner transferred or disposed
of, in whole or in part. The Shares, nor any interest in them, may not be sold,
assigned, hypothecated, encumbered or in any other manner transferred or
disposed of, in whole or in part, except in compliance with the Act and state
securities laws and the terms and conditions hereof. Upon exercise of this
Warrant,

                                       6
<PAGE>   7

unless the Shares being acquired are registered under the Act and any applicable
state securities laws or an exemption from such registration is available, the
Holder shall confirm in writing that the Shares so purchased are being acquired
for investment and not with a view toward distribution or resale in violation of
the Act and shall confirm such other matters related thereto as may be
reasonably requested by the Company. This Warrant and all Shares issued upon
exercise of this Warrant (unless at the time of acquisition they are registered
under the Act and any applicable state securities laws) shall be stamped or
imprinted with a legend in substantially the following form:

               "THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER
               THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE
               SECURITIES LAWS. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON
               TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD
               EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES
               LAWS, PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. THE
               ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN
               FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT
               ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND
               ANY APPLICABLE STATE SECURITIES LAWS."

Any certificate for Shares issued at any time in exchange or substitution for
any certificate for any Shares bearing such legend (except a new certificate for
any Shares issued after the acquisition of such Shares pursuant to a
registration statement which has been declared effective under the Act) shall
also bear such legend unless, in the opinion of counsel for the Company, the
Shares represented thereby are no longer subject to the restrictions set forth
herein. The provisions of this Article 6 shall be binding upon all subsequent
Holders of certificates for Shares bearing the above legend and all subsequent
Holders of this Warrant, if any.

        6.2 Investment Representations. In addition, in connection with the
issuance of this Warrant, the Holder specifically represents to the Company by
acceptance of this Warrant as follows:

               (a) The Holder is aware of the Company's business affairs and
financial condition and has acquired information about the Company sufficient to
reach an informed and knowledgeable decision to acquire this Warrant. The Holder
is acquiring this Warrant for its own account for investment purposes only and
not with a view to, or for the resale in connection with, any "distribution"
thereof in violation of the Act. The Holder is an "accredited investor" as
defined in Rule 501 promulgated under the Act.

               (b) The Holder understands that this Warrant has not been
registered under the Act in reliance upon a specific exemption therefrom, which
exemption depends upon, among other things, the bona fide nature of the Holder's
investment intent as expressed herein.

                                       7
<PAGE>   8

               (c) The Holder further understands that this Warrant must be held
indefinitely unless subsequently registered under the Act and qualified under
any applicable state securities laws or unless exemptions from registration and
qualification are otherwise available. The Holder understands that the Company
is under no obligation to register and qualify this Warrant or the Shares
underlying the Warrant.

               (d) The Holder is aware of the provisions of Rule 144 promulgated
under the Act, which, in substance, permit limited public resale of "restricted
securities" acquired, directly or indirectly, from the issuer thereof (or from
an affiliate of the issuer), in a nonpublic offering subject to the satisfaction
of certain conditions, if applicable, including, without limitation, the
availability of certain public information about the Company, the resale
occurring not less than one year after the party has purchased and paid for the
securities to be sold, the sale being made through a broker in an unsolicited
"broker transaction" or in transactions directly with a market maker and the
amount of securities being sold during any three (3) month period not exceeding
certain specified limitations.

               (e) The Holder further understands that at the time it wishes to
sell this Warrant or the Shares there may be no public market upon which to make
such a sale and that, even if such public market then exists, the Company may
not be satisfying the current public information requirements under Rule 144
promulgated under the Act and that, in such event, the Holder may be precluded
from selling this Warrant under Rule 144 even if the one year minimum holding
period has been satisfied.

               (f) The Holder further understands that in the event that all the
requirements of Rule 144 are not met, registration under the Act, compliance
with Regulation A or some other registration exemption will be required; and
that, notwithstanding the fact that Rule 144 under the Act is not exclusive, the
staff of the Securities and Exchange Commission (the "COMMISSION") has expressed
its opinion that persons proposing to sell private placement securities other
than in a registered offering or pursuant to Rule 144 will have a substantial
burden of proof in establishing that an exemption from registration is available
for such offers or sales, and that such persons and their respective brokers who
participate in such transactions do so at their own risk.

        6.3 Disposition of Warrant or the Shares. With respect to any offer,
sale or other disposition of this Warrant or any Shares acquired pursuant to the
exercise of this Warrant prior to registration of this Warrant or such Shares,
the Holder agrees to give written notice to the Company prior thereto,
describing briefly the manner thereof, together with a written opinion of the
Holder's counsel, or, if reasonably requested by the Company, other evidence to
the effect that such offer, sale or other disposition may be effected without
registration or qualification (under the Act as then in effect or any federal or
state securities law then in effect) of this Warrant or such Shares and
indicating whether or not under the Act certificates for this Warrant or such
Shares to be sold or otherwise disposed of require any restrictive legend as to
applicable restrictions on transferability in order to ensure compliance with
such law. If a determination has been made pursuant to this Section 6.3 that the
opinion of counsel for the Holder or other evidence is not reasonably
satisfactory to the Company, the Company shall so notify the Holder promptly
with details thereof after such determination has been made. Notwithstanding the
foregoing, this Warrant or the Shares may be offered, sold or otherwise disposed
of if (a) the

                                       8
<PAGE>   9

Company shall have been furnished with a letter from the Commission, in response
to a written request in form and substance acceptable to counsel for the Company
setting forth all of the facts and circumstances surrounding the contemplated
transfer, stating that the Commission will take no action with regard to the
contemplated transfer; or (b) the Shares are transferred pursuant to a
registration statement which has been filed with the Commission and has become
effective. The Company may issue stop transfer instructions to its transfer
agent to enforce the foregoing restrictions. Notwithstanding the foregoing, no
such opinion of counsel shall be required in instances of transfers of the
Shares or the Warrant to any affiliate (as such term is defined by Rule 405
under the Act) of Holder, provided the Company is notified of such transfer and
so long as such transfer complies with all applicable laws, rules and
regulations.

        6.4 Termination of Restrictions and Removal of Legend. Except for the
restriction set forth in Section 2.6, the restrictions on transfer imposed by
this Article 6 shall cease and terminate as to the Shares when (i) such
securities shall have been effectively registered under the Act and sold by the
Holder in accordance with such registration, (ii) an acceptable opinion or other
evidence as described in Section 6.3 or a "no action" letter described in
Section 6.3 states that future transfers of such securities by the transferor or
the contemplated transferee would be exempt from registration under the Act, or
(iii) such securities may be sold under and in accordance with Rule 144(k)
promulgated by the Commission under the Act. When the restrictions on transfer
contained in this Article 6 have terminated as provided above, the Holder or the
transferee of the Holder shall be entitled to receive promptly from the Company,
without expense to it, and upon surrender of existing certificates, new
certificates not bearing the legend set forth in Section 6.1 hereof.

ARTICLE 7. MISCELLANEOUS.

        7.1 Liquidated Damages. Holder acknowledges and agrees that the Company
is issuing certain of the Warrants to Holder in connection with Holder selecting
the Company as internal print procurement provider for its North America
operations and, in connection therewith, Holder agrees to not publicly disclose
the internal use of any other print procurement system (other than Ariba or
Fatbrain) for a period of 18 months after the installation of the Web Site.
Notwithstanding anything to the contrary set forth in this Warrant, in the event
that Holder makes such a public disclosure during such 18 month period, Holder
agrees that any Warrants not yet exercised will become null and void on the date
of such public disclosure, Holder shall forfeit any shares of Common Stock it
holds which were obtained through exercise of the Warrant and, to the extent
Holder has exercised the Warrant and sold the underlying shares of Common Stock,
Holder agrees that it will pay to the Company as liquidated damages any profits
recognized by Holder in connection with such transactions.

        7.2 No Impairment. The Company shall not by amendment of its Certificate
of Incorporation avoid or seek to avoid the observance or performance of any of
the terms to be observed or performed under this Warrant by the Company.

        7.3 Agreement for Lock-up. The Holder, by acceptance hereof, agrees that
such Holder will not, without the prior written consent of the lead underwriter
in connection with the IPO, directly or indirectly offer to sell, contract to
sell (including, without limitation, any short

                                       9
<PAGE>   10

sale), pledge, grant any option for the sale of, acquire any option to dispose
of, or otherwise dispose of any Shares or securities into which such Share are
converted for a period of 180 days following the closing of the IPO.

        7.4 Notices. All notices and other communications from the Company to
the Holder, or vice versa, shall be deemed delivered and effective when given
personally or mailed by first-class registered or certified mail, postage
prepaid, at such address as may have been furnished by the Company or the
Holder, as the case may be, in writing by the Company or the Holder from time to
time.

        7.5 No Inconsistent Agreements. The Company has not previously entered
into, and will not on or after the date of this Warrant enter into, any
agreement with respect to its securities which is inconsistent with the terms of
this Warrant, including any agreement which impairs or limits the rights granted
to the Holder in this Warrant, or which otherwise conflicts with the provisions
hereof or would preclude the Company from discharging its obligations hereunder.

        7.6 Modification and Waiver. This Warrant and any term hereof may be
changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of such change, waiver, discharge
or termination is sought.

        7.7 Attorneys' Fees. In the event of any dispute between the parties
concerning the terms and provisions of this Warrant, the party prevailing in
such dispute shall be entitled to collect from the other party all costs
incurred in such dispute, including reasonable attorneys' fees.

        7.8 Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant. The language in this Warrant shall be
construed as to its fair meaning without regard to which party drafted this
Warrant.

        7.9 Survival of Representations, Warranties and Agreements. All
representations and warranties of the Company and the Holder contained herein
shall survive the Date of Grant, the exercise or conversion of this Warrant (or
any part hereof) or the termination or expiration of rights hereunder. All
agreements of the Company and the Holder contained herein shall survive
indefinitely until, by their respective terms, they are no longer operative.

        7.10 Remedies. In case any one or more of the covenants and agreements
contained in this Warrant shall have been breached, the Holder (in the case of a
breach by the Company), or the Company (in the case of a breach by a Holder),
may proceed to protect and enforce its rights either by suit in equity and/or by
action at law, including, but not limited to, an action for damages as a result
of any such breach and/or an action for specific performance of any such
covenant or agreement contained in this Warrant.

        7.11 Severability. The invalidity or unenforceability of any provision
of this Warrant in any jurisdiction shall not affect the validity or
enforceability of such provision in any other jurisdiction, or affect any other
provision of this Warrant, which shall remain in full force and effect.

                                       10
<PAGE>   11

        7.12 Entire Agreement. This Warrant constitutes the entire agreement
between the parties pertaining to the subject matter contained in it and
supersedes all prior and contemporaneous agreements, representations, and
undertakings of the parties, whether oral or written, with respect to such
subject matter.

        7.13 Governing Law. This Warrant shall be governed by and construed in
accordance with the laws of the State of Delaware, without giving effect to its
principles regarding conflicts of law.

                            [SIGNATURE PAGE FOLLOWS]

                                       11
<PAGE>   12

Date of Grant: March ___, 2000

                                          PRINTCAFE, INC.

                                          By: __________________________________

                                          Name:

                                          Title:

REVIEWED, ACKNOWLEDGED AND AGREED TO THIS ___ DAY OF MARCH, 2000

ANDERSEN CONSULTING LLP

By: _______________________________

Name:

Title:

<PAGE>   13

                                    EXHIBIT A

                               NOTICE OF EXERCISE

To:  printCafe, Inc. (the "Company")

        1. The undersigned hereby:

               [ ]    elects to purchase __________ shares of Common Stock of
                      the Company pursuant to the terms of the attached Warrant,
                      and tenders herewith payment of the purchase price of such
                      shares in full, or

               [ ]    elects to exercise its Conversion Right pursuant to
                      Article 3 of the attached Warrant with respect to
                      __________ shares of Common Stock.

        2. Please issue a certificate or certificates representing said shares
in the name of the undersigned or in such other name or names as are specified
below:

                        ________________________________
                                     (Name)

                        ________________________________

                        ________________________________

                        ________________________________
                                    (Address)

        3. The undersigned represents that the aforesaid shares are being
acquired for the account of the undersigned for investment and not with a view
to, or for resale in connection with, the distribution thereof and that the
undersigned has no present intention of distributing or reselling such shares,
all except as in compliance with applicable securities laws.

                                       _______________________________________
                                       (Signature)

                                       Date:

<PAGE>   14

                                   EXHIBIT A-1

                               NOTICE OF EXERCISE

To: printCafe, Inc., (the "Company")

        1. Contingent upon and effective immediately prior to the closing (the
"Closing") of the Company's public offering contemplated by the Registration
Statement on Form S , filed , 20 , the undersigned hereby:

               [ ]    elects to purchase ____________ shares of Common Stock of
                      the Company (or such lesser number of shares as may be
                      sold on behalf of the undersigned at the Closing) pursuant
                      to the terms of the attached Warrant, or

               [ ]    elects to exercise its Conversion Right pursuant to
                      Article 3 of the attached Warrant with respect
                      ____________ shares of Common Stock.

        2. Please deliver to the custodian for the selling stockholders a stock
certificate representing such __________ shares.

        3. The undersigned has instructed the custodian for the selling
stockholders to deliver to the Company $________ or, if less, the net proceeds
due the undersigned from the sale of shares in the aforesaid public offering. If
such net proceeds are less than the purchase price for such shares, the
undersigned agrees to deliver the difference to the Company prior to the
Closing.

                                       _______________________________________
                                       (Signature)

                                       Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00004-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00004-of-00352.parquet"}]]